Series |
S. hrg. ; 118-56 United States. Congress. Senate. S. hrg. ; https://id.loc.gov/authorities/names/n83707917 ; 118-56. ^A500722
|
General note | In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP). |
General note | GPO Cataloging Record Distribution Program (CRDP). |
Bibliography note | Includes bibliographical references. |
Performer |
Hearing witnesses: Andrew Shuman, M.D., Associate Professor of Otolaryngology-Head and Neck Surgery, and Chief of the Clinical Ethics Service Center for Bioethics and Social Sciences in Medicine, University of Michigan Medical School; Vimala Raghavendran, Vice President Informatics Product Development, U.S. Pharmacopeia; Erin Fox, Pharm.D., Associate Chief Pharmacy Officer of Shared Services and Adjunct Professor, College of Pharmacy, University of Utah; John C. Goodman, Ph.D., President Goodman Institute for Public Policy Research. |
Date/time/place of a event note | Date of hearing: 2023-03-22. |
Source of description | Description based on online resource; title from PDF title screen (GovInfo, viewed Aug. 14, 2023). |
Issued in other form | Print version: United States. Congress. Senate. Committee on Homeland Security and Governmental Affairs. Drug shortage health and national security risks |
Genre/form | Legislative hearings. |
Standard identifier# |
52-496 (GPO jacket number) |
GPO item number | 1037-D (online) |
Govt. docs number |
Y 4.G 74/9:S.HRG.118-56 |